Remme Carol Ann, Wilde Arthur A M, Bezzina Connie R
Department of Experimental Cardiology, Heart Failure Research Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Trends Cardiovasc Med. 2008 Apr;18(3):78-87. doi: 10.1016/j.tcm.2008.01.002.
Cardiac sodium channel dysfunction caused by mutations in the SCN5A gene is associated with a number of relatively uncommon arrhythmia syndromes, including long-QT syndrome type 3 (LQT3), Brugada syndrome, conduction disease, sinus node dysfunction, and atrial standstill, which potentially lead to fatal arrhythmias in relatively young individuals. Although these various arrhythmia syndromes were originally considered separate entities, recent evidence indicates more overlap in clinical presentation and biophysical defects of associated mutant channels than previously appreciated. Various SCN5A mutations are now known to present with mixed phenotypes, a presentation that has become known as "overlap syndrome of cardiac sodium channelopathy." In many cases, multiple biophysical defects of single SCN5A mutations are suspected to underlie the overlapping clinical manifestations. Here, we provide an overview of current knowledge on SCN5A mutations associated with sodium channel overlap syndromes and discuss a possible role for modifiers in determining disease expressivity in the individual patient.
由SCN5A基因突变引起的心脏钠通道功能障碍与多种相对罕见的心律失常综合征有关,包括3型长QT综合征(LQT3)、Brugada综合征、传导疾病、窦房结功能障碍和心房停搏,这些疾病可能导致相对年轻个体发生致命性心律失常。尽管这些不同的心律失常综合征最初被认为是独立的疾病,但最近的证据表明,相关突变通道的临床表现和生物物理缺陷比以前认识到的有更多重叠。现在已知各种SCN5A突变会表现出混合表型,这种表现被称为“心脏钠通道病重叠综合征”。在许多情况下,单个SCN5A突变的多种生物物理缺陷被怀疑是重叠临床表现的基础。在这里,我们概述了与钠通道重叠综合征相关的SCN5A突变的当前知识,并讨论了修饰因子在确定个体患者疾病表达中的可能作用。